Katarina Luptakova insider trades
Open-market stock purchases and sales by Katarina Luptakova, CHIEF MEDICAL OFFICER at Xilio Therapeutics, Inc, from SEC Form 4 filings since Sep 5, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 1, 2026 | XLO Xilio Therapeutics, Inc | Bought (not open market) | — |
| Dec 31, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | — |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Sold (not open market) | $94.2K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | $52.5K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Sold (not open market) | $69.6K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | $159K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | — |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Sold (not open market) | $428K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | $66.3K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Sold (not open market) | $35.5K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | $22.5K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | $37.5K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Sold (not open market) | $296K |
Companies traded
- XLO Xilio Therapeutics, Inc: other filings, last Jan 1, 2026